SCHEMBL314782

SCHEMBL314782

CC(C)(CBr)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3714427 0.83 ACLY (0.31)
SCHEMBL22080420 0.78 TSHR (0.35)
SCHEMBL7826296 0.78 TRPA1 (0.37)
SCHEMBL1854344 0.77
SCHEMBL791722 0.75
SCHEMBL477823 0.75
SCHEMBL13886363 0.75
Hydrochloric Acid SCHEMBL4441658 0.75 ACLY (0.45)
SCHEMBL320771 0.73 ACLY (0.54)
SCHEMBL797973 0.73 TSHR (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115299313-A Ecological greening spray-seeding adsorption bio-based fiber soil and preparation method thereof 中奥生态环境股份有限公司 2022-11-08 CN claimed
CN-114369214-A Block-controllable ultrahigh molecular weight copolymer and synthesis method thereof 长春市兆兴新材料技术有限责任公司 2022-04-19 CN claimed
CN-107400090-B Synthesis method of benzimidazole derivative 华润赛科药业有限责任公司 2020-02-07 CN claimed
WO-2025096654-A1 COMPOSITIONS AND INHIBITORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
WO-2025096662-A1 COMPOSITIONS AND INHIBITORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
WO-2025096658-A1 COMPOSITIONS AND INHIBITORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
WO-2025096653-A1 COMPOSITIONS AND INHIBITORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
WO-2025096657-A1 COMPOSITIONS AND INHIBITORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
WO-2025096660-A1 COMPOSITIONS AND INHIBITORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
US-11931428-B2 Selective hydrogen sulfide probe and uses thereof WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) 2024-03-19 US disclosed
US-11905306-B2 Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus SOUTHERN RESEARCH INSTITUTE (US) 2024-02-20 US disclosed
US-5202321-A Antihistamine, antiallergens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1993-04-13 US disclosed
EP-0518426-A1 Thiopyrano (2,3,4-c,d) indoles as inhibitors of leukotriene biosynthesis MERCK FROSST CANADA INC. (CA) 1992-12-16 EP disclosed
US-5104882-A Leukotriene antagonists MERCK FROSST CANADA, INC. (CA) 1992-04-14 US disclosed
EP-0399818-A1 Diarylstyrylquinoline diacids MERCK FROSST CANADA INC. (CA) 1990-11-28 EP disclosed
EP-0369553-A1 Process for the enantioselective preparation of D-(-)-3-hal-2-methylpropionic acid or derivatives thereof and the preparation of captopril therefrom DSM N.V. (NL) 1990-05-23 EP disclosed
US-4405357-A Herbicidal 3-isoxazolidinones and hydroxamic acids FMC CORPORATION (US) 1983-09-20 US disclosed
US-4198416-A 5-Alkoxy-picolinic esters and anti-hypertensive composition containing 5-alkoxy-picolinic esters MEIJI SEIKA KAISHA, LTD. (JP) 1980-04-15 US disclosed
US-4189489-A 5-Alkoxy-picolinic acid calcium salts and anti-hypertensive composition containing 5-alkoxy-picolinic acid calcium salts and anti-hypertensive composition thereof MEIJI SEIKA KAISHA, LTD. (JP) 1980-02-19 US disclosed
US-4002730-A Radionuclide carriers THE PROCTER & GAMBLE COMPANY (US) 1977-01-11 US disclosed